Skip to main content
Full access
Article
Published Online: 1 June 2010

Time to Attainment of Recovery From Borderline Personality Disorder and Stability of Recovery: A 10-year Prospective Follow-Up Study

Abstract

Objective

The purposes of this study were to determine time to attainment of recovery from borderline personality disorder and to assess the stability of recovery.

Method

A total of 290 inpatients who met both DSM-III-R and Revised Diagnostic Interview for Borderlines criteria for borderline personality disorder were assessed during their index admission using a series of semistructured interviews and self-report measures. The same instruments were readministered every 2 years for 10 years.

Results

Over the study period, 50% of participants achieved recovery from borderline personality disorder, which was defined as remission of symptoms and having good social and vocational functioning during the previous 2 years. Overall, 93% of participants attained a remission of symptoms lasting at least 2 years, and 86% attained a sustained remission lasting at least 4 years. Of those who achieved recovery, 34% lost their recovery. Of those who achieved a 2-year remission of symptoms, 30% had a symptomatic recurrence, and of those who achieved a sustained remission, only 15% experienced a recurrence.

Conclusions

Taken together, the results of this study suggest that recovery from borderline personality disorder, with both symptomatic remission and good psychosocial functioning, seems difficult for many patients to attain. The results also suggest that once attained, such a recovery is relatively stable over time.

Formats available

You can view the full content in the following formats:

Information & Authors

Information

Published In

Go to American Journal of Psychiatry
Go to American Journal of Psychiatry
American Journal of Psychiatry
Pages: 663 - 667
PubMed: 20395399

History

Received: 7 August 2009
Accepted: 14 December 2009
Published online: 1 June 2010
Published in print: June 2010

Authors

Details

Mary C. Zanarini, Ed.D.
Frances R. Frankenburg, M.D.
D. Bradford Reich, M.D.
Garrett Fitzmaurice, Sc.D.

Notes

Received Aug. 7, 2009; revisions received Oct. 6 and Dec. 7, 2009; accepted Dec. 14, 2009. From McLean Hospital. Address correspondence and reprint requests to Dr. Zanarini, McLean Hospital, 115 Mill St., Belmont, MA 02478; [email protected] (e-mail).

Competing Interests

Dr. Zanarini has received research support from AstraZeneca. The other authors report no financial relationships with commercial interests.

Funding Information

Supported by NIMH grants MH47588 and MH62169.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Full Text

View Full Text

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - American Journal of Psychiatry

PPV Articles - American Journal of Psychiatry

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share